Compounds > chlorotrianisene
Page last updated: 2024-08-21

chlorotrianisene and Carcinoma

chlorotrianisene has been researched along with Carcinoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
EVANS, AT; RUSH, TW; SMITH, PG1
Alken, CE; Dhom, G; Hohbach, M; Sachse, D; Schröder, FH; Straube, W1

Other Studies

2 other study(ies) available for chlorotrianisene and Carcinoma

ArticleYear
Preliminary report on the clinical use of tace (chlorotrianisene) in treatment of prostatic carcinoma.
    The Journal of urology, 1951, Volume: 65, Issue:5

    Topics: ADAM Proteins; ADAM17 Protein; Carcinoma; Chlorotrianisene; Embolization, Therapeutic; Estrogens; Humans; Male; Prostate; Prostatic Neoplasms

1951
[Therapy and follow-up study of the prostatic neoplasm].
    Der Urologe. Ausg. A, 1972, Volume: 11, Issue:4

    Topics: Adenocarcinoma; Aged; Biopsy; Carcinoma; Cell Nucleus; Chlorotrianisene; Estradiol; Evaluation Studies as Topic; Follow-Up Studies; Humans; Inclusion Bodies; Male; Middle Aged; Prostatectomy; Prostatic Neoplasms; Radiotherapy, High-Energy; Stilbenes; Testis

1972